| Sign In to gain access to subscriptions and/or personal tools. |
Pharmacological Studies on the Anti-inflammatory Action of Phenolic CompoundsDepartment of Dental Pharmacology, School of Dentistry, Asahi University, Hozumi, Hozumi-Cho, Motosu-Gun, Gifu 501-02, Japan
Department of Dental Pharmacology, School of Dentistry, Asahi University, Hozumi, Hozumi-Cho, Motosu-Gun, Gifu 501-02, Japan
Department of Dental Pharmacology, School of Dentistry, Asahi University, Hozumi, Hozumi-Cho, Motosu-Gun, Gifu 501-02, Japan
Department of Dental Pharmacology, School of Dentistry, Asahi University, Hozumi, Hozumi-Cho, Motosu-Gun, Gifu 501-02, Japan The mechanism of the anti-inflammatory action of phenolic compounds was examined using neutrophil chemotaxis. Chemotactic activity of guinea pig peritoneal neutrophils to N-formylmethionyl-leucylphenylalanine (FMLP) was suppressed in a concentration-dependent manner. The order of drug potency in inhibiting the neutrophil chemotaxis was eugenol » thymol > guaiacol » phenol. The concentrations of phenolic compounds used in these experiments did not induce lactate dehydrogenase (LDH) release and did not affect neutrophil viability. There was a consistent positive relation between the ID50 of superoxide anion generation in neutrophils and the inhibitory dose for neutrophil chemotaxis by phenolic compounds. A free phenolic hydroxyl group is essential for scavenging oxygen free-radicals and is also essential for inhibiting leukocyte chemotaxis, as was demonstrated in these experiments. These findings suggest that inhibition of leukocyte chemotaxis may be involved in the anti-inflammatory action of phenolic compounds, and that one of the anti-inflammatory actions of phenolic compounds is the prevention of the production of oxygen free-radicals by leukocytes.
Journal of Dental Research, Vol. 65, No. 1,
53-56 (1986) This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||


